In cervical cancer (CCa), GDF15 promotes tumor proliferation by upregulating CyclinD1 and CyclinE1 while downregulating p21 via the PI3K/AKT and MAPK/ERK pathways in conjunction with ErbB2 [124]. Here, ERBB2 is linked to neoplasm.